IN2012DN06278A - - Google Patents
Info
- Publication number
- IN2012DN06278A IN2012DN06278A IN6278DEN2012A IN2012DN06278A IN 2012DN06278 A IN2012DN06278 A IN 2012DN06278A IN 6278DEN2012 A IN6278DEN2012 A IN 6278DEN2012A IN 2012DN06278 A IN2012DN06278 A IN 2012DN06278A
- Authority
- IN
- India
- Prior art keywords
- polypeptides
- directed
- present
- use production
- microalgal cells
- Prior art date
Links
- 101710133291 Hemagglutinin-neuraminidase Proteins 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18651—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Virology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29046909P | 2009-12-28 | 2009-12-28 | |
| PCT/US2010/062274 WO2011082189A1 (en) | 2009-12-28 | 2010-12-28 | Production of hemagglutinin-neuraminidase protein in microalgae |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN06278A true IN2012DN06278A (enrdf_load_html_response) | 2015-09-25 |
Family
ID=44226795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN6278DEN2012 IN2012DN06278A (enrdf_load_html_response) | 2009-12-28 | 2010-12-28 |
Country Status (9)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI324181B (en) | 2001-04-16 | 2010-05-01 | Martek Biosciences Corp | Product and process for transformation of thraustochytriales microorganisms |
| ES2752196T3 (es) | 2009-03-16 | 2020-04-03 | Dsm Ip Assets Bv | Producción de proteínas en microorganismos del filo Labyrinthulomycota |
| AR079767A1 (es) * | 2009-12-28 | 2012-02-15 | Merial Ltd | Antigeno ndv (virus de la enfermedad de newcastle) recombinante y usos del mismo |
| EP2519635B1 (en) * | 2009-12-28 | 2018-11-21 | Sanofi Vaccine Technologies, S.A.S. | Production of heterologous polypeptides in microalgae, microalgal extracellular bodies, compositions, and methods of making and uses thereof |
| MX378719B (es) | 2010-01-19 | 2025-03-11 | Dsm Ip Assets Bv | Microorganismos productores de acido eicosapentenoico, composiciones de acido graso, y metodos de elaboracion y usos de los mismos. |
| BR112014001126B1 (pt) | 2011-07-21 | 2022-05-10 | Dsm Ip Assets B.V | Composição contendo óleo microbiano refinado e forma de dosagem oral |
| CN103525785B (zh) * | 2013-09-24 | 2015-03-25 | 西北大学 | 一种分离纯化神经氨酸酶（禽流感病毒）的方法 |
| WO2016140925A1 (en) | 2015-03-02 | 2016-09-09 | Synthetic Genomics, Inc. | Regulatory elements from labyrinthulomycetes microorganisms |
| EP3535385A4 (en) | 2016-11-01 | 2020-06-17 | Conagen Inc. | EXPRESSION OF MODIFIED GLYCOPROTEINS AND GLYCOPEPTIDES |
| US10633454B2 (en) | 2016-11-01 | 2020-04-28 | Conagen Inc. | Expression of modified glycoproteins and glycopeptides |
| WO2019213095A1 (en) * | 2018-05-01 | 2019-11-07 | Conagen Inc. | Recombinant organisms and methods for producing glycomolecules with high glycan occupancy |
| IL312997A (en) | 2021-11-30 | 2024-07-01 | Sanofi Pasteur Inc | Human metapneumovirus vaccines |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4659669A (en) | 1981-03-02 | 1987-04-21 | Regents Of The Univ. Of California | Microbial expression of human influenza hemagglutinin proteins |
| US4752473A (en) | 1984-10-12 | 1988-06-21 | The Regents Of The University Of California | Expression of glycosylated human influenza hemagglutinin proteins |
| US5340742A (en) | 1988-09-07 | 1994-08-23 | Omegatech Inc. | Process for growing thraustochytrium and schizochytrium using non-chloride salts to produce a microfloral biomass having omega-3-highly unsaturated fatty acids |
| US5762939A (en) | 1993-09-13 | 1998-06-09 | Mg-Pmc, Llc | Method for producing influenza hemagglutinin multivalent vaccines using baculovirus |
| WO1997039106A1 (en) * | 1996-04-12 | 1997-10-23 | Martek Biosciences Corporation | Methods and tools for transformation of eukaryotic algae |
| WO1999002695A2 (en) | 1997-07-08 | 1999-01-21 | Stichting Instituut Voor Dierhouderij En Diergezondheid | Epitopes and active sites of paramyxoviridae proteins and uses thereof |
| US8003772B2 (en) * | 1999-01-14 | 2011-08-23 | Martek Biosciences Corporation | Chimeric PUFA polyketide synthase systems and uses thereof |
| US7795002B2 (en) | 2000-06-28 | 2010-09-14 | Glycofi, Inc. | Production of galactosylated glycoproteins in lower eukaryotes |
| EP1522590B1 (en) | 2000-06-28 | 2009-08-26 | Glycofi, Inc. | Methods for producing modified glycoproteins |
| US7625756B2 (en) | 2000-06-28 | 2009-12-01 | GycoFi, Inc. | Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells |
| US20060029604A1 (en) | 2000-06-28 | 2006-02-09 | Gerngross Tillman U | Immunoglobulins comprising predominantly a GlcNAc2Man3GlcNAc2 glycoform |
| US20060257399A1 (en) | 2000-06-28 | 2006-11-16 | Glycofi, Inc. | Immunoglobulins comprising predominantly a Man5GIcNAc2 glycoform |
| TWI324181B (en) * | 2001-04-16 | 2010-05-01 | Martek Biosciences Corp | Product and process for transformation of thraustochytriales microorganisms |
| US7332299B2 (en) | 2003-02-20 | 2008-02-19 | Glycofi, Inc. | Endomannosidases in the modification of glycoproteins in eukaryotes |
| AU2004235813B2 (en) | 2003-05-05 | 2010-07-29 | Boyce Thompson Institute For Plant Research | Vectors and cells for preparing immunoprotective compositions derived from transgenic plants |
| DE602004015775D1 (de) * | 2003-06-05 | 2008-09-25 | Wyeth Corp | Immunogene zusammensetzungen, die replikonvektoren des venezolanischen pferdeencephalitisvirus und paramyxovirus-proteinantigene enthalten |
| AU2005248375B2 (en) | 2004-05-25 | 2010-12-16 | Medimmune, Llc | Influenza hemagglutinin and neuraminidase varians |
| US8936930B2 (en) * | 2004-08-05 | 2015-01-20 | Ben-Gurion University Of The Negev Research And Development Authority | Red microalgae expressing exogenous polypeptides and methods of generating and utilizing same |
| JP4796786B2 (ja) * | 2005-04-28 | 2011-10-19 | 富士フイルム株式会社 | ラビリンチュラ類を形質転換可能なベクター |
| JP4796787B2 (ja) * | 2005-04-28 | 2011-10-19 | 富士フイルム株式会社 | ラビリンチュラ類への遺伝子導入法 |
| US20070245431A1 (en) | 2006-03-15 | 2007-10-18 | Martek Biosciences Corporation | Polyunsaturated fatty acid production in heterologous organisms using pufa polyketide synthase systems |
| CA2615372A1 (en) | 2007-07-13 | 2009-01-13 | Marc-Andre D'aoust | Influenza virus-like particles (vlps) comprising hemagglutinin |
| EP2090648A1 (en) * | 2008-02-12 | 2009-08-19 | Institut Francais de Recherche pour l'Exploitation de la Mere(Ifremer) | Production of glycosylated polypeptides in microalgae |
| ES2752196T3 (es) | 2009-03-16 | 2020-04-03 | Dsm Ip Assets Bv | Producción de proteínas en microorganismos del filo Labyrinthulomycota |
| AR079767A1 (es) | 2009-12-28 | 2012-02-15 | Merial Ltd | Antigeno ndv (virus de la enfermedad de newcastle) recombinante y usos del mismo |
| EP2519635B1 (en) | 2009-12-28 | 2018-11-21 | Sanofi Vaccine Technologies, S.A.S. | Production of heterologous polypeptides in microalgae, microalgal extracellular bodies, compositions, and methods of making and uses thereof |
-
2010
- 2010-12-28 IN IN6278DEN2012 patent/IN2012DN06278A/en unknown
- 2010-12-28 WO PCT/US2010/062274 patent/WO2011082189A1/en active Application Filing
- 2010-12-28 EA EA201290565A patent/EA030095B1/ru unknown
- 2010-12-28 AU AU2010339544A patent/AU2010339544B2/en active Active
- 2010-12-28 CA CA2785867A patent/CA2785867C/en active Active
- 2010-12-28 EP EP10841650.4A patent/EP2519636B8/en active Active
- 2010-12-28 US US12/980,320 patent/US9012197B2/en active Active
- 2010-12-28 CN CN201080064860.1A patent/CN103068984B/zh not_active Expired - Fee Related
- 2010-12-28 JP JP2012547248A patent/JP5838473B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2785867A1 (en) | 2011-07-07 |
| EP2519636A4 (en) | 2013-07-03 |
| CN103068984B (zh) | 2017-12-01 |
| JP2013515502A (ja) | 2013-05-09 |
| AU2010339544A1 (en) | 2012-08-09 |
| US20110195480A1 (en) | 2011-08-11 |
| CA2785867C (en) | 2018-03-27 |
| EP2519636B8 (en) | 2017-08-09 |
| EA030095B1 (ru) | 2018-06-29 |
| US9012197B2 (en) | 2015-04-21 |
| WO2011082189A1 (en) | 2011-07-07 |
| JP5838473B2 (ja) | 2016-01-06 |
| EP2519636A1 (en) | 2012-11-07 |
| AU2010339544B2 (en) | 2015-11-12 |
| EA201290565A1 (ru) | 2013-02-28 |
| EP2519636B1 (en) | 2017-03-01 |
| CN103068984A (zh) | 2013-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN06278A (enrdf_load_html_response) | ||
| JOP20180103B1 (ar) | التركيب الصيدلاني للكاربيتوسين | |
| IN2014CN02100A (enrdf_load_html_response) | ||
| IN2014CN03072A (enrdf_load_html_response) | ||
| MX2013001540A (es) | Composiciones que comprende un polipeptido que tiene actividad de incremento celulolititico y un compuesto de quinona, y uso de las mismas. | |
| PH12013500760B1 (en) | Microorganism producing o-phosphoserine and method of producing l-cysteine or derivatives thereof from o-phosphoserine using the same | |
| MX339809B (es) | Metodo para preparar anticuerpos con propiedades mejoradas. | |
| EA201290567A1 (ru) | Получение гетерологичных полипептидов в микроводорослях, внеклеточные микроводорослевые тельца, композиции и способы их получения и применения | |
| SG10201900948PA (en) | Modified nucleotide linkers | |
| IN2014CN00688A (enrdf_load_html_response) | ||
| AU2011356210A8 (en) | Novel fucosyltransferases and their applications | |
| MX2015006324A (es) | Metodos para la fabricacion de polipeptidos proteoliticamente procesados. | |
| MX2019004568A (es) | Produccion mejorada de derivados de acidos grasos. | |
| WO2014153346A8 (en) | Engineering a heterogeneous tissue from pluripotent stem cells | |
| WO2011159684A3 (en) | Generation of induced pluripotent stem cells from small volumes of peripheral blood | |
| MX2013013913A (es) | Polipeptidos. | |
| MX350211B (es) | Proceso para la preparacion del etil-ester del acido n- (4-ciclohexil-3-trifluoro-metil-benciloxi) -acetimidico. | |
| MX2011013112A (es) | Solventes novedosos para la produccion de dispersiones de poliuretano. | |
| IN2014DN10710A (enrdf_load_html_response) | ||
| PH12013500694A1 (en) | Process for manufacturing dihydropteridinones and intermediates thereof | |
| NZ607149A (en) | Galacto-oligosaccharide-containing composition and a method of producing it | |
| MX2011012623A (es) | Construcciones de casb7439. | |
| MX349544B (es) | Extractos de maesa japonica y métodos de uso. | |
| MY166449A (en) | Pharmaceutical composition of rosuvastatin calcium | |
| MY160625A (en) | Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation |